INDV
INDV
US45579U1097
Indivior Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.239.000.000 1.188.000.000
4.3%
Cost of Revenue 246.000.000 231.000.000
6.5%
Gross Profit 993.000.000 957.000.000
3.8%
728.000.000 723.000.000
0.7%
Operating Income 265.000.000 234.000.000
13.2%
Pretax Income 239.000.000 20.000.000
1095.0%
Net Income Common Stockholders 210.000.000 7.000.000
2900.0%
-- --
--
-- --
--
ende